Company Filing History:
Years Active: 2025
Title: Fangming Cheng: Innovator in Virus Detection Technology
Introduction
Fangming Cheng is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of virus detection, particularly in the development of innovative antibodies and diagnostic kits. His work is crucial in the ongoing fight against viral infections, including COVID-19.
Latest Patents
Fangming Cheng holds a patent for IgA antibodies and kits capable of specifically recognizing the RBD protein. This patent relates to the technical field of virus detection and provides a method for detecting IgA antibodies against the RBD protein of SARS-CoV-2. The antibody serves as a calibrator, enabling automated, high-throughput, and rapid detection of IgA antibodies related to novel coronavirus pneumonia.
Career Highlights
Cheng is associated with Shenzhen Yhlo Biotech Co., Ltd., where he applies his expertise in biotechnology to develop advanced diagnostic solutions. His work has been instrumental in enhancing the accuracy and efficiency of virus detection methods.
Collaborations
Fangming Cheng collaborates with notable colleagues, including Xiaotao Lin and Zhisheng Dang. Their combined efforts contribute to the advancement of innovative technologies in the field of biotechnology.
Conclusion
Fangming Cheng's contributions to virus detection technology exemplify the importance of innovation in healthcare. His work not only aids in the detection of viral infections but also enhances public health responses to emerging diseases.